The α2C-adrenoceptor antagonist JP-1302 controls behavioral parameters, tyrosine hydroxylase activity and receptor expression in a rat model of ketamine-induced schizophrenia-like deficits
Autor: | Tekin, Nurdan, Karamahmutoğlu, Tuğba Eryiğit, Aykaç, Aslı, Akakın, Dilek, Gören, Mehmet Zafer |
---|---|
Zdroj: | In Pharmacology, Biochemistry and Behavior November 2022 221 |
Databáze: | ScienceDirect |
Externí odkaz: |